ConductScience.org, home

Paper7005035

Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.

Breddin K and 4 others. Haemostasis, 1980. Cited by 93 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Papers, record 7005035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7005035

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.
PubMed
Journal
Haemostasis
PubMed
Year
1980
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
3.18
iCite
Revised in PubMed
2018-02-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Breddin KK
2Loew DD
3Lechner KK
4Uberla KK
5Walter EE

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
4-HydroxycoumarinsMajor topic
AspirinMajor topic
Myocardial InfarctionMajor topic
PhenprocoumonMajor topic
Aged
Clinical Trials as Topic
Female
Hemorrhage
Humans
Male
Middle Aged
Patient Compliance
Random Allocation
Sex Factors
Sulfinpyrazone

Source PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
23,539,414Plasminogen activators and ischemic stroke: conditions for acute delivery.Semin Thromb Hemost2013https://conductscience.org/library/papers/23539414PubMed
11,406,726Aspirin in patients with coronary artery disease: is it simply irresistible?J Thromb Thrombolysis2001https://conductscience.org/library/papers/11406726PubMed
11,067,652Economic assessment of the secondary prevention of ischaemic events with lysine acetylsalicylate.Pharmacoeconomics2000https://conductscience.org/library/papers/11067652PubMed
10,211,350Platelets, aspirin, and cardiovascular disease.Postgrad Med J1998https://conductscience.org/library/papers/10211350PubMed
9,554,904
North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.
BMJ1998https://conductscience.org/library/papers/9554904PubMed
8,471,398The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8471398PubMed
8,298,418
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
BMJ1994https://conductscience.org/library/papers/8298418PubMed
7,711,618Prophylactic aspirin and risk of peptic ulcer bleeding.BMJ1995https://conductscience.org/library/papers/7711618PubMed
7,106,166Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7106166PubMed
6,865,264[Reversible inhibition of thrombocyte stimulation by acetylsalicylic acid and its role in antithrombotic therapy].Klin Wochenschr1983https://conductscience.org/library/papers/6865264PubMed
6,716,908[Effects of acetylsalicylic acid on partial functions of human thrombocytes are not inhibited in vivo by salicylic acid].Klin Wochenschr1984https://conductscience.org/library/papers/6716908PubMed
6,714,288Oral anticoagulation in patients surviving myocardial infarction. A new approach to old data.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6714288PubMed
3,987,774Plasma salicylate levels and platelet function after acute and chronic administration of slow-release acetylsalicylic acid (Monobeltin).Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3987774PubMed
3,905,338Risk of haemorrhage associated with long term anticoagulant therapy.Drugs1985https://conductscience.org/library/papers/3905338PubMed
3,366,158Plasma drug and antiplatelet profiles of the original acetylsalicylic acid preparations used in the AMIS, PARIS and German-Austrian trials for secondary prevention of myocardial infarction.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3366158PubMed
3,125,883Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.Br Med J (Clin Res Ed)1988https://conductscience.org/library/papers/3125883PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7005035

GET https://conductscience.org/api/papers/v1/7005035/authors